• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Ann Clin Microbiol Antimicrob . MERS-CoV: epidemiology, molecular dynamics, therapeutics, and future challenges

tetano

Editor, Senior Moderator
Ann Clin Microbiol Antimicrob


. 2021 Jan 18;20(1):8.
doi: 10.1186/s12941-020-00414-7.
MERS-CoV: epidemiology, molecular dynamics, therapeutics, and future challenges


Ali A Rabaan[SUP] 1 [/SUP], Shamsah H Al-Ahmed[SUP] 2 [/SUP], Ranjit Sah[SUP] 3 [/SUP], Mohammed A Alqumber[SUP] 4 [/SUP], Shafiul Haque[SUP] 5 [/SUP], Shailesh Kumar Patel[SUP] 6 [/SUP], Mamta Pathak[SUP] 6 [/SUP], Ruchi Tiwari[SUP] 7 [/SUP], Mohd Iqbal Yatoo[SUP] 8 [/SUP], Abrar Ul Haq[SUP] 9 [/SUP], Muhammad Bilal[SUP] 10 [/SUP], Kuldeep Dhama[SUP] 11 [/SUP], Alfonso J Rodriguez-Morales[SUP] 12 13 14 [/SUP]



Affiliations

Abstract

The Severe Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has gained research attention worldwide, given the current pandemic. Nevertheless, a previous zoonotic and highly pathogenic coronavirus, the Middle East Respiratory Syndrome coronavirus (MERS-CoV), is still causing concern, especially in Saudi Arabia and neighbour countries. The MERS-CoV has been reported from respiratory samples in more than 27 countries, and around 2500 cases have been reported with an approximate fatality rate of 35%. After its emergence in 2012 intermittent, sporadic cases, nosocomial infections and many community clusters of MERS continued to occur in many countries. Human-to-human transmission resulted in the large outbreaks in Saudi Arabia. The inherent genetic variability among various clads of the MERS-CoV might have probably paved the events of cross-species transmission along with changes in the inter-species and intra-species tropism. The current review is drafted using an extensive review of literature on various databases, selecting of publications irrespective of favouring or opposing, assessing the merit of study, the abstraction of data and analysing data. The genome of MERS-CoV contains around thirty thousand nucleotides having seven predicted open reading frames. Spike (S), envelope (E), membrane (M), and nucleocapsid (N) proteins are the four main structural proteins. The surface located spike protein (S) of betacoronaviruses has been established to be one of the significant factors in their zoonotic transmission through virus-receptor recognition mediation and subsequent initiation of viral infection. Three regions in Saudi Arabia (KSA), Eastern Province, Riyadh and Makkah were affected severely. The epidemic progression had been the highest in 2014 in Makkah and Riyadh and Eastern Province in 2013. With a lurking epidemic scare, there is a crucial need for effective therapeutic and immunological remedies constructed on sound molecular investigations.

Keywords: Challenges; Epidemiology; MERS-CoV; Molecular dynamics; Pathology; Phylogeny; SARS-CoV-2; Therapeutics.
 
Back
Top